Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Up First Briefing: Alzheimer's drug; Ukraine cluster bombs; tap water chemicals

The FDA approved the first drug shown to slow down Alzheimer's. The Biden administration will send controversial cluster bombs to Ukraine. A study estimates PFAS is in nearly half of U.S. tap water.

WEKU

Miracle new Alzheimer's drug which slows cognitive decline of disease to be rolled out

The Food and Drug Administration (FDA) has approved the much awaited drug Leqembi which has been shown to slow the cognitive decline caused by Alzheimer’s, the most common type of dementia

Daily Mirror

FDA fully approves new Alzheimer’s drug to slow down disease progression

‘Today’s action is first verification that a drug targeting underlying disease process has shown clinical benefit’

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA approves new Alzheimer's drug

Leqembi has proven to slow the progression of the disease, while others only target its symptoms

Salon

US government approves Alzheimer’s drug to slow cognitive decline

Some insurances, including the government-run Medicare, refused to pay for the drug until it received full approval.

Al Jazeera

Eisai Alzheimer's drug gets full US approval, widening access to the therapy

Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from U.S. regulators Thursday, a move expected to widen access to the first drug cleared based on its ability to slow progression of the mind-robbing disease.

Tribune News Service

FDA approves Leqembi, first drug to slow Alzheimer’s progression

Eisai and Biogen's Leqembi is the first drug to slow Alzheimer's progression to receive full FDA approval.

Axios

Read news from The Economist, FT, and more,
with one subscription

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it

U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease

The Independent UK

Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

WEKU

FDA grants full approval to new Alzheimer’s drug - Roll Call

The drug Leqembi targets plaque buildup in the brain, and it is approved for people in the early stages of the disease.

Roll Call

Health warning as cases of little known disease skyrocket and 'tripledemic' looms

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks

Daily Mirror

AbbVie (ABBV) vs. Pfizer (PFE) - Which Pharma Stock Comes out on Top?

With the growing prevalence of chronic conditions, an aging population, widespread adoption of digital technologies, and several R&D efforts, the pharmaceutical industry is poised for exponential growth and expansion. So, let’s compare leading pharma stocks AbbVie (ABBV) and Pfizer (PFE) to identify which is a better investment now. Keep reading….

StockNews.com

Test approved to detect preeclampsia, leading cause of US maternal deaths

FDA approves new test, which has been widely celebrated as a small victory in the fight to make childbirth safer in the US

The Guardian - US

The plan to dodge another tripledemic

Vaccines to stave off the flu, a new COVID variant and now, respiratory syncytial virus could help avert another tripledemic this fall. Unless the public is too crisis-fatigued to care.

Axios

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

As low-nicotine cigarettes hit the market, anti-smoking groups press for wider standard

The idea seems simple enough.

Salon

Is aspartame actually that harmful?

"While reports like these can understandably be worrying, there's no reason to panic at this stage"

Inverse

A Long-Awaited Vaccine For Lyme Disease is Tantalizingly Close — Here's When It Could Be Available

Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine.

The Conversation

According to reports, the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), is set to declare the artificial sweetener aspartame as “possibly carcinogenic to humans”.

Get all your
news in one place.

100's of premium titles.
One news app.

Marie Claire

Exosome Therapy Is Ushering in the Next Generation of Skin and Hair Rejuvenation

“Think of exosomes as the body’s own information superhighway.”

Laptop

Apple AirPods may double as hearing aids in the future — you'll finally stop saying 'huh?!'

Apple is reportedly working on adding several new game-changing health perks to the AirPods, including hearing-enhancing features and other cool additions.

WEKU

Abortion access could continue to change in year 2 after the overturn of Roe v. Wade

It's already harder to get an abortion in many places and access is likely to be limited more with the passage of new laws.

Salon

New bill to ban toxic chemicals in food

"Things like this aren’t partisan. They’re common sense," said former governor Arnold Schwarzenegger

Apple's AirPods could become HearPods

Apple's earbuds could deliver better health tracking and help your hearing too

The Independent UK

Australia is the first nation to let patients with depression or PTSD be prescribed psychedelics

Australia is now the first country to allow psychiatrists to prescribe certain psychedelic substances to patients with depression or post-traumatic stress disorder

Tribune News Service

Humira, the world’s top-selling drug, faces an upcoming test from low cost alternatives

If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor.

1 … 132 133 134 135

People

Arnold Schwarzenegger

920 stories

Mangeet Kaur BounsMangeet

Chiquita BrooksLaSure

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the Food and Drug Administration

214 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.